Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 31,191 shares at $22.16 ($688K) on 2025-12-17, disclosed to the SEC on 2025-12-18.
Scheduled sale ($688k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.88 | 11,225 | $246K | 35.7% |
| 2 | $22.16 | 9,983 | $221K | 32.2% |
| 3 | $22.16 | 9,983 | $221K | 32.2% |
| Total | $22.06 avg | 31,191 | $688K | 100% |
| Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |
| RCUS | SELL | 2024-02-28 | $2.4M | — | Filing → |